Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Multiple sclerosis: Characterization of lesion evolution in relapsing-remitting and secondary progressive multiple sclerosis.
Immune Therapy of Multiple Sclerosis - Future Strategies.
Recommendations for the detection and therapeutic management of cognitive impairment in multiple sclerosis.
Cryptococcal Meningoencephalitis in a Patient With Multiple Sclerosis Treated With Fingolimod.
The role of B cells in the onset of the first demyelinating event of optic neuritis.
Prevalence and clinical features of multiple sclerosis in Latin America.
Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions.
Remyelination Therapy for Multiple Sclerosis.
Analysis of "task-positive" and "task-negative" functional networks during the performance of the Symbol Digit Modalities Test in patients at presentation with clinically isolated syndrome suggestive of multiple sclerosis.
Torque teno virus (TTV) in multiple sclerosis patients with different patterns of disease.
Immunosuppressive monoclonal antibodies: current and next generation.
Smoking and inflammation: evidence for a synergistic role in chronic disease.
"People power" or "pester power"? YouTube as a forum for the generation of evidence and patient advocacy.
Decoding Signaling and Function of the Orphan G Protein-Coupled Receptor GPR17 with a Small-Molecule Agonist.
ApoTransferrin: Dual Role on Adult Subventricular Zone-Derived Neurospheres.
Trigger, pathogen, or bystander: the complex nexus linking Epstein- Barr virus and multiple sclerosis.
Cooperative roles of NF-κB and NFAT4 in polyomavirus JC regulation at the KB control element.
No association of IFI16 (interferon-inducible protein 16) variants with susceptibility to multiple sclerosis.
Active Biotech's partner Teva initiates a laquinimod clinical trial in Huntington's disease
Optic neuritis in a psoriatic arthritis patient treated by infliximab.
The effect of gabapentin on oxidative stress in a model of toxic demyelination in rat brain.
Vitamin D and multiple sclerosis: what is the clinical impact?
Validity and reliability of the Serbian version of Patient-Reported Impact of Spasticity Measure in multiple sclerosis.
Type I interferons as ambiguous modulators of chronic inflammation in the central nervous system.
Prevalence of Radiologically Isolated Syndrome and White Matter Signal Abnormalities in Healthy Relatives of Multiple Sclerosis Patients.

Pages